| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of type 2 diabetes with polymyalgia rheumatica accompanied by marked prothrombin time-international normalized ratio elongation
|
Ogo, Atsushi
|
|
2011
|
2 |
4 |
p. 214-218
|
artikel
|
| 2 |
A case report of type 2 diabetes mellitus with biatrial thrombi and pulmonary embolism caused by atrial fibrillation: successful treatment with anticoagulant therapy
|
Inoue, Tomoaki
|
|
2011
|
2 |
4 |
p. 219-222
|
artikel
|
| 3 |
Administration of insulin glargine thrice weekly by medical staff at a dialysis unit: a new insulin regimen for diabetic management in physically impaired patients undergoing hemodialysis
|
Bouchi, Ryotaro
|
|
2011
|
2 |
4 |
p. 197-201
|
artikel
|
| 4 |
A single-nucleotide polymorphism in the human THADA gene is associated with circulating resistin in the general Japanese population
|
Kawamura, Ryoichi
|
|
2011
|
2 |
4 |
p. 190-196
|
artikel
|
| 5 |
Cases with Hb Toranomon show abnormal HbA1c levels measured by upgraded high-performance liquid chromatography models
|
Ijima, Hiroko
|
|
2011
|
2 |
4 |
p. 202-207
|
artikel
|
| 6 |
Clinical features of Japanese type 2 diabetics with insulinogenic index in normal range after treatment of glucotoxicity
|
Iwahashi, Hiromi
|
|
2011
|
2 |
4 |
p. 208-213
|
artikel
|
| 7 |
Converse contributions of fasting and postprandial glucose to HbA1c and glycated albumin
|
Sakuma, Nobuko
|
|
2011
|
2 |
4 |
p. 162-171
|
artikel
|
| 8 |
Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects
|
Kadokura, Takeshi
|
|
2011
|
2 |
4 |
p. 172-182
|
artikel
|
| 9 |
Prevention of disaster
|
Atsumi, Yoshihito
|
|
2011
|
2 |
4 |
p. 159
|
artikel
|
| 10 |
Role of the podocyte signal-transduction systems in the pathogenesis of diabetic nephropathy
|
Kaburagi, Yasushi
|
|
2011
|
2 |
4 |
p. 160-161
|
artikel
|
| 11 |
Safety and efficacy of switching thrice-daily treatment with NovoRapid®70Mix (BIAsp70) to BIAsp70 before breakfast and lunch and NovoRapid®30Mix (BIAsp30) before dinner in patients with type 2 diabetes: subgroup analysis of a phase III trial
|
Kadowaki, Takashi
|
|
2011
|
2 |
4 |
p. 183-189
|
artikel
|
Tijdschrift beschrijving